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DEV8341All multipotent hematopoietic progenitors in C57BL-
Thy-1.1 bone marrow are divided among three subpopu-
lations of Thy-1.1loSca-1+Lin -- /loc-kit+ cells: long-term
reconstituting Mac-1 -- CD4 -- c-kit+ cells and transiently
reconstituting Mac-1loCD4 -- or Mac-1loCD4lo cells. This
study shows that the same populations, with similar func-
tional activities, exist in mice whose hematopoietic
systems were reconstituted by hematopoietic stem cells
after lethal irradiation. We demonstrate that these popu-
lations form a lineage of multipotent progenitors from
long-term self-renewing stem cells to the most mature
multipotent progenitor population. In reconstituted mice,
Mac-1 -- CD4 -- c-kit+ cells gave rise to Mac-1loCD4 -- cells,
which gave rise to Mac-1loCD4lo cells. Mac-1 -- CD4 -- c-kit+
cells had long-term self-renewal potential, with each cell
being capable of giving rise to more than 104 functionally
similar Mac-1 -- CD4 -- c-kit+ cells. At least half of Mac-
1loCD4 -- cells had transient self-renewal potential,
detected in the spleen 7 days after reconstitution. Mac-
1loCD4lo cells did not have detectable self-renewal
potential. The identification of a lineage of multipotent
progenitors provides an important tool for identifying
genes that regulate self-renewal and lineage commitment.
Key words: hematopoietic stem cell, lineage, transplantation, self-
renewal, bone marrow, blood, stem cell
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The bone marrow multipotent progenitor pool must satisfy the
conflicting demands of life-long self-renewal as well as the
need to give rise to large numbers of mature blood cells each
day. Two models of hematopoietic stem cell (HSC) differen-
tiation and self-renewal have been advanced based on the
reconstituting activity of whole bone marrow: clonal succes-
sion (Kay, 1965) and the generation age hypothesis (Rosendaal
et al., 1979). Both models postulated the existence of different
classes of HSC including rare quiescent cells that maintain the
progenitor pool over the long-term and larger numbers of
cycling multipotent progenitors, with limited self-renewal
potential, that give rise to lineage committed progenitors (Kay,
1965; Hellman et al., 1978; Rosendaal et al., 1979). Micklem
and Ogden (1976) predicted that bone marrow multipotent
progenitors must be divided into a lineage of at least three
distinct populations. They predicted that the most immature
population would have long-term self-renewal potential, few
cells in cycle and the ability to give rise to very large numbers
of progeny. The intermediate population(s) would have less
self-renewal potential, more cells in cycle and the ability to
give rise to fewer progeny. The most mature multipotent pro-
genitor population prior to lineage commitment was postulated
to have little self-renewal potential and a high proportion of
cells in cycle (Micklem and Ogden, 1976).
We have purified three populations of bone marrow multi-
potent hematopoietic progenitors with properties that are con-
sistent with the hypothetical lineage of stem cells proposed in
the models (Morrison and Weissman, 1994). The mostprimitive population is Thy-1loSca-1+Lin- Mac-1- CD4 - c-kit+
(referred to as Mac-1- CD4- c-kit+) representing approximately
0.007% of bone marrow. 80% of single cells transplanted in
vivo are multipotent and have long-term self-renewal potential.
Only around 4% of cells are in S/G2/M phases of the cell cycle
at any time. Thy-1loSca-1+Lin - Mac-1loCD4- cells (referred to
as Mac-1loCD4- ) represent around 0.01% of bone marrow.
Most cells in this population are transiently reconstituting mul-
tipotent progenitors and 7% of cells are in S/G2/M phases on
average. Thy-1loSca-1+Mac-1loCD4lo cells (referred to as Mac-
1loCD4lo) average 0.03% of bone marrow and 18% of cells are
in S/G2/M phases of the cell cycle. This population contains a
mixture of transiently reconstituting multipotent progenitors
and progenitors that only give rise to detectable B cells. These
populations include all multipotent hematopoietic progenitors
in C57BL-Thy-1.1 mice (Uchida and Weissman, 1992).
We hypothesized that the three Thy-1loSca-1+Lin- /lo sub-
populations form a lineage in which Mac-1- CD4- c-kit+ cells
give rise to Mac-1loCD4- cells, which give rise to Mac-
1loCD4lo cells. This paper describes the results of extensive
analyses of reconstituted mice and secondary transfer experi-
ments that tested this hypothesis.
MATERIALS AND METHODS
Mouse strains
C57BL/J (Ly5.1, Thy-1.2) and C57BL/Ka-Thy1.1 (Ly 5.2) mouse
strains were bred and maintained on acidified water (pH 2.5) at the
animal care facility at the Stanford University School of Medicine.
1930 S. J. Morrison and othersNormal donors of multipotent progenitors were 6-10 weeks old. Irra-
diated recipient mice were 8 to 14 weeks old at the time of irradia-
tion.
Antibodies
The antibodies used in immunofluorescence staining included
19XE5 (anti-Thy1.1), AL1-4A2 (anti-Ly5.2), A20.1 (anti-Ly5.1),
2B8 (anti-c-kit) and E13 (anti-Sca-1, Ly6A/E). Lineage marker anti-
bodies included KT31.1 (anti-CD3), 53-7.3 (anti-CD5), 53-6.7 (anti-
CD8), Ter119 (anti-erythrocyte specific antigen), 6B2 (anti-B220)
and 8C5 (anti-Gr-1). M1/70 (anti-Mac-1) and GK1.5 (anti-CD4)
staining of hematopoietic populations were described separately
from the lineage cocktail to distinguish long-term and transient
progenitor populations.
Bone marrow preparation and staining 
Marrow was flushed from the femurs and tibias of donor mice. Single-
cell suspensions were prepared by drawing the bone marrow cells
through a 25-gauge needle, then expelling them back through the
needle and through a nylon mesh screen. Cells were suspended in
Hanks’ balanced salt solution (HBSS, without phenol red) (Applied
Scientific, San Francisco, CA) containing 2% calf serum. 
For HSC purification, cells were incubated with a cocktail of
unlabeled lineage marker antibodies including those specific for CD3,
CD4, CD5, CD8, Gr-1, Ter119, B220 and Mac-1. All antibody incu-
bations were for 20 minutes on ice, prior to diluting the cells and cen-
trifuging through a calf serum cushion. The cells were incubated with
PE-conjugated anti-rat antibody to visualize the lineage markers. The
cells were then incubated with 19XE5FITC, E13bio and 2B8APC. When
donor-type HSC were sorted from reconstituted mice, A20.1PE was
included in the lineage cocktail to further discriminate recipient-type
from donor-type progenitors (in addition to the Thy-1 difference). If
a Mac-1lo population was to be sorted, then Mac-1 was not included
in the lineage cocktail and M1/70APC was used instead of 2B8APC.
Similarly, if Mac-1loCD4lo cells were sorted then CD4PE replaced the
lineage cocktail. Sca-1+ cells were sometimes pre-enriched by
positive selection using MACS® streptavidin-conjugated magnetic
beads according to the manufacturer’s instructions. The cells were
resuspended in 0.5 m g/ml of propidium iodide (PI) prior to FACS
analysis.
Cell sorting and analyses
Most analyses and all cell sorts were performed on a dual laser
FACS® (Becton Dickinson, Mountain View, CA), modified as
described (Parks and Herzenberg, 1984). Progenitors were usually
purified by sorting and then resorting to obtain precise numbers of
cells, which were essentially pure for the indicated surface marker
phenotype. In the case of single cell clonogenic assays, the resort was
performed in cloning mode in which single cells were deposited into
methylcellulose medium in a 96-well plate or into stromal cell cultures
in a 24-well plate.
Functional analyses
Long-term reconstitution of lethally irradiated mice, day 12 CFU-S,
colony formation on AC-6 stroma and colony formation in methyl-
cellulose were assayed as described previously (Morrison et al.,
1996b).
RESULTS
The isolation of multipotent progenitors from
reconstituted mice
We sought to determine whether the subpopulations of Thy-
1loSca-1+Lin - /lo cells that contain all multipotent progenitors
in normal C57BL-Thy-1.1 (Ly5.2) bone marrow also containthe multipotent progenitor activity in reconstituted mice.
C57BL/J (Thy-1.2, Ly5.1) mice were lethally irradiated and
reconstituted with 60 Mac-1 - CD4 - c-kit+ cells from a C57BL-
Thy-1.1 (Ly5.2) donor. On average 1 out of 10 Mac-1 - CD4 -
c-kit+ cells from normal marrow engrafts and gives rise to
detectable progenitor activity upon intravenous injection
(Morrison and Weissman, 1994). If 15% of bone marrow is in
the femurs and tibia (Smith and Clayton, 1970), the long bones
of a mouse injected with 60 Mac-1 - CD4 - c-kit+ cells would be
reconstituted on average by a single progenitor cell. 2-15
weeks later, Mac-1 - CD4 - c-kit+, Mac-1loCD4 - or Mac-
1loCD4lo cells were purified by fluorescence activated cell
sorting (FACS) from the reconstituted mice. Donor-derived
progenitors were distinguished from host-derived progenitors
by selecting cells expressing Thy-1.1 and by excluding Ly5.1+
cells. Donor-type Mac-1 - CD4 - c-kit+, Mac-1loCD4 - and Mac-
1loCD4lo cells were purified from the reconstituted recipients.
The purified cells were tested for progenitor activity in
long-term reconstitution assays in which 15 to 100 cells from
either population were competed against a radioprotective
dose of 200,000 recipient-type whole bone marrow cells.
When purified from normal bone marrow, only 10 cells from
any of these populations consistently reconstituted 60 to 70%
of recipients (Morrison and Weissman, 1994). At doses of 15
to 30 cells, the Mac-1 - CD4 - c-kit+ population isolated from
reconstituted mice exhibited detectable progenitor activity in
only 1 out of 35 recipients. Nine of nine mice in one exper-
iment and four of five mice in a second experiment were
reconstituted by 15 Mac-1 - CD4 - c-kit+ cells purified from
normal donors. This demonstrates that the difference in pro-
genitor activity between Mac-1 - CD4 - c-kit+ cells purified
from normal and reconstituted mice is highly significant
(P<0.001). At higher cell doses, long-term multilineage
progenitor activity was readily observed from the Mac-1 -
CD4 - c-kit+ population purified from reconstituted mice. Fig.
1 shows the reconstitution profiles of nine mice competitively
reconstituted with 100 Mac-1 - CD4 - c-kit+ cells purified 13
weeks after the reconstitution of primary recipients with
Mac-1 - CD4 - c-kit+ cells from normal bone marrow. Of the
individuals shown in the figure, five were long-term multi-
lineage reconstituted (LTMR), three were transiently multi-
lineage reconstituted (TMR) and one was reconstituted only
by myeloid and B cells. Overall, of 30 mice competitively
reconstituted by 50 to 100 Mac-1 - CD4 - c-kit+ cells purified
from reconstituted mice, ten were LTMR, seven were TMR,
eight were reconstituted only in one or two lineages, and five
mice were unreconstituted by donor-type cells. Thus Mac-1 -
CD4 - c-kit+ cells purified from reconstituted mice exhibit
progenitor activity in competitive reconstitution assays much
less frequently than the same population from normal bone
marrow. Although Mac-1 - CD4 - c-kit+ cells from reconsti-
tuted mice are highly enriched for LTMR activity, they
include a higher proportion of cells that exhibit transient
progenitor activity than normal bone marrow Mac-1 - CD4 - c-
kit+ cells.
Similar results were obtained from Mac-1loCD4- cells
purified from reconstituted mice. Of mice injected with 15-25
cells, only 7 of 33 recipients became competitively reconstituted
by donor-type cells (1 LTMR, 3 TMR, 3 oligopotent reconsti-
tutions). However, 21 of 23 mice injected with 15 Mac-1loCD4-
cells purified from a normal donor became competitively recon-
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Weeks after Reconstitution
Fig. 1. Levels of donor
cell reconstitution in
irradiated mice
reconstituted by Thy-
1loSca-1+Lin- Mac-1-
CD4- c-kit+ (Mac-1-
CD4- c-kit+) cells purified
from mice reconstituted
by Mac-1 - CD4- c-kit+
cells from normal
marrow 13 weeks
previously. Fifteen
secondary recipients
received 100 donor-type
Mac-1 - CD4- c-kit+ cells
plus 200,000 host-type
whole bone marrow cells
for radioprotection. Each
line represents an
individual mouse and the
shaded area represents
the range of background
signals observed in
negative control mice.
Overall 14 mice were
reconstituted by donor-
type cells including 5 that
were long-term
multilineage
reconstituted (LTMR), 4
that were transiently
multilineage
reconstituted, 3
reconstituted only by B
and T cells, 1
reconstituted only by
donor-type B cells and 1
reconstituted only by
myeloid and B cells. For
purposes of clarity, the
figure depicts the
reconstitution profiles of
9 of these mice including
5 that were LTMR (open
square, filled square,
open circle, filled circle,
X), 3 that were
transiently multilineage
reconstituted (filled
diamond, open triangle,
filled triangle) and 1
reconstituted only by
donor lymphoid cells
(open diamonds).stituted, demonstrating that the difference in the reconstituting
activity of Mac-1loCD4- cells purified from normal and recon-
stituted donors is highly significant (P<0.001). At higher celldoses, transient multipotent progenitor activity was readily
observed from Mac-1loCD4- cells purified from reconstituted
mice. Fig. 2 shows the donor cell reconstitution profiles of five
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Fig. 2. Lethally irradiated
mice were reconstituted by
60 Thy-1loSca-1+Lin-
Mac-1- CD4- c-kit+ cells.
15 weeks later Thy-1loSca-
1+Lin- Mac-1loCD4-
(Mac-1loCD4- ) cells were
purified by FACS from the
bone marrow of these
primary recipients and
transferred to lethally
irradiated secondary
recipients. Five secondary
recipients received 75
donor-type Mac-1loCD4-
cells plus 200,000 host-
type whole bone marrow
cells for radioprotection.
Each line represents an
individual mouse and the
shaded area represents the
range of background
signals observed in
negative control mice.
Four secondary recipients
were transiently
multilineage reconstituted
by donor-type cells (open
square, filled square, open
diamond, filled triangle)
and one mouse was
reconstituted by donor-
type B and T cells (filled
diamonds).mice competitively reconstituted with 75 Mac-1loCD4- cells.
Four of five mice were TMR and one was donor reconstituted
only by B and T cells. Relative to Mac-1loCD4- cells from
normal bone marrow, a higher dose of cells from reconstitutedmice was required to observe progenitor activity in the com-
petitive reconstitution assay. Nonetheless, Mac-1loCD4- cells
from both sources exhibit mainly transient multipotent and oli-
gopotent progenitor activity.
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Fig. 3. Lethally irradiated
mice were reconstituted by
60 Thy-1loSca-1hiLin-
Mac-1- CD4- c-kit+ cells. 4
weeks later Thy-1loSca-
1hiMac-1loCD4lo (Mac-
1loCD4lo) cells were
purified by FACS from the
bone marrow of these
primary recipients and
transferred to lethally
irradiated secondary
recipients. Five secondary
recipients received 50
donor-type Mac-1loCD4lo
cells plus 200,000
recipient-type whole bone
marrow cells for
radioprotection. Each line
represents an individual
mouse, and the shaded area
represents the range of
background signals
observed in negative
control mice. Three
secondary recipients were
transiently multilineage
reconstituted by donor-
type cells (closed square,
open diamond, filled
diamond), one mouse was
reconstituted only by
donor-type B cells (closed
triangles) and one mouse
was unreconstituted by
donor-type cells (open
squares).In reconstituted mice, the Mac-1loCD4lo population only
exhibited progenitor activity when purified from the bone
marrow of mice within 4 weeks of reconstitution. 4 weeks afterreconstitution by Mac-1 - CD4- c-kit+ cells, bone marrow was
harvested from primary recipients and Mac-1loCD4lo cells
were purified. 50 of these cells were injected into each of ten
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Table 1. Functional activities of Thy-1lo Sca-1+ Lin -- /lo c-kit+ subpopulations purified from normal mice, and mice
reconstituted by 60 Mac-1 -- CD4 -- c-kit+ HSC
HSC reconstituted donors Normal donors
Mac-1- CD4 - c-kit+ Mac-1loCD4- Mac-1loCD4lo Mac-1- CD4- c-kit+ Mac-1loCD4- Mac-1loCD4lo
Day 12 CFU-S (1/freq) 15 12±1 No activity 61±29 14±4 18±8
Clonogenic on stroma (%) 31±14 44±20 0 49±10 55±9 40±5
Clonogenic in culture (%) 67±10 53±4 0 83±1 62 26±5
The percentage of cells clonogenic on stroma was determined by sorting single cells into individual AC-6 stromal cell cultures and then counting the
percentage of wells that formed colonies. To determine the percentage of cells clonogenic in culture, individual cells were deposited into methylcellulose cultures
supplemented by IL-3, IL-6 and SlF, cytokines that maximize colony formation by multipotent progenitors. Mac-1loCD4lo cells from HSC reconstituted donors
were obtained from mice that had been reconstituted for 10-15 weeks. Some of the data from normal donors have been published elsewhere and are presented
here for comparison purposes only (Morrison and Weissman, 1994; Morrison et al., 1996b). Statistics are presented as means ± s.d.secondary recipients, competitively reconstituting four with
donor-type cells. Fig. 3 shows five of ten secondary recipients,
including the four that became reconstituted by donor-type
cells (3 TMR and 1 oligopotent reconstitution). By compari-
son, 19 of 21 mice injected with 15 Mac-1loCD4lo cells purified
from normal mice were competitively reconstituted by donor
cells (difference significant at P<0.001). When Mac-1loCD4lo
cells were purified 8-15 weeks after reconstitution, 50-100
cells did not transfer detectable progenitor activity to any of 25
secondary recipients. Although higher cell doses were required
to exhibit progenitor activity, the Mac-1loCD4lo population
purified from reconstituted donors within a month of reconsti-
tution exhibited similar types of progenitor activity as the same
population from normal bone marrow.
The inefficient engraftment of multipotent progenitor popu-
lations from reconstituted mice might be due to either a
reduced ability to home to and engraft bone marrow or the
presence of a majority of non-progenitor cells within each
population. In order to distinguish between these possibilities,
we tested the activities of these cells in functional assays that
are independent of bone marrow homing properties. The results
are summarized in Table 1. We assayed the day 12 colony
forming unit-spleen (CFU-S) activity of all three populations
purified from primary recipients 10-15 weeks after reconstitu-
tion. Day 12 CFU-S activity is associated with multipotent
progenitors (for example, Spangrude et al., 1988; Morrison and
Weissman, 1994). The CFU-S activities of the Mac-1- CD4- c-
kit+ and Mac-1loCD4 - populations from reconstituted mice
were equal to or greater than those from normal mice (Table
1). This is inconsistent with the multipotent progenitor popu-
lations from reconstituted mice containing a majority of non-
progenitor cells or progenitors more differentiated than multi-
potent progenitors. 
The ability of single cells to form colonies on AC-6 stroma
was also tested. The colonies formed by these populations
contained hundreds of thousands of cells and persisted for
more than 6 weeks. Progenitors forming such colonies have
recently been shown to be equivalent to LTC-IC (Muller-
Sieburg and Riblet, 1996). 31% of Mac-1 - CD4 - c-kit+ cells
and 44% of Mac-1loCD4 - cells from reconstituted mice
formed such colonies on AC-6 stroma (Table 1). Around 50%
of cells from either population purified from normal marrow
formed indistinguishable colonies (Morrison et al., 1996b).
The frequency of Mac-1 - CD4 - c-kit+ cells from reconstituted
mice that formed colonies on AC-6 was modestly but signif-
icantly (P<0.05) reduced relative to those from normal bone
marrow. Even if this modest reduction resulted entirely fromcontamination due to non-progenitor cells, it could not
account for the observed 8-fold reduction in engraftment in
vivo. The frequency of colony formation by Mac-1loCD4 -
cells did not significantly differ between normal and recon-
stituted donors. 
We tested the ability of these populations to form colonies
in methylcellulose supplemented with IL-3, IL-6 and Steel
factor (SlF) — cytokines that optimize colony formation by
multipotent progenitors (Heimfeld et al., 1991; Tsuji et al.,
1992; Morrison et al., 1996b). 67% of Mac-1- CD4- c-kit+ cells
and 53% of Mac-1loCD4- cells from reconstituted mice formed
colonies in methylcellulose (Table 1). 83 or 62% of the same
populations from normal marrow formed similar colonies
under the same conditions. The rate of colony formation from
progenitor populations isolated from reconstituted mice was
somewhat reduced relative to the same cells from normal
marrow, but the differences were not statistically significant.
Multipotent progenitors from reconstituted mice might not be
able to respond as efficiently as normal bone marrow multipo-
tent progenitors to in vitro clonogenic assays; however, the data
are also consistent with the Mac-1- CD4- c-kit+ and Mac-
1loCD4- populations from reconstituted mice containing a
small but increased proportion of non-progenitor cells. The
presence of non-clonogenic cells in the populations from
reconstituted mice could contribute to their reduced engraft-
ment efficiency. Based on the in vitro assays, the non-clono-
genic Mac-1- CD4- c-kit+ cells from reconstituted mice appear
to represent less than a third of the population, but the engraft-
ment rate of these cells in irradiated recipients was more than
8-fold reduced relative to normal bone marrow Mac-1- CD4- c-
kit+ cells. The data suggest that the reduced reconstituting effi-
ciency of multipotent progenitors from reconstituted mice is
due mainly to a reduced ability of bonafide progenitors to home
to and engraft in the bone marrow of recipient mice. Proof of
this interpretation depends on the development of an in vivo
homing assay for HSC that can be performed using relatively
few cells.
The Mac-1loCD4lo population, purified from mice that had
been reconstituted for 10-15 weeks, had no CFU-S activity or
progenitor activity in culture. This is consistent with its lack of
progenitor activity in vivo when purified from the bone marrow
of mice that have been reconstituted for more than 4 weeks.
Mac-1loCD4lo progenitors also disappeared during normal
aging in old mice (Morrison et al., 1996b). We did not test the
CFU-S activity or the progenitor activity in culture of Mac-
1loCD4lo cells from the marrow of primary recipients within 4
weeks of reconstitution.
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Table 2. The presence of multipotent progenitor
populations in the bone marrow of mice reconstituted by
Mac-1 -- CD4 -- c-kit+, Mac-1loCD4 -- , or Mac-1loCD4lo cells
from normal marrow
Donor-derived progenitors
Primary recipients Time after in primary recipients
reconstituted by reconstitution Mac-1- CD4- c-kit+ Mac-1loCD4 -
Mac-1- CD4- c-kit+ 3-6 weeks 6/9 4/9
>6 weeks 15/16 13/14
Mac-1loCD4- 3-6 weeks 1/9 1/9
>6 weeks 0/1 0/1
Mac-1loCD4lo 3-6 weeks 0/6 0/6
>6 weeks 1/4 1/4
In each case, the number of primary recipients positive for each progenitor
population is shown as a proportion of recipients examined. Primary
recipients are organized according to the progenitor population that they were
reconstituted by. In each case, primary recipients were reconstituted by 60
cells of the given population and their bone marrow was harvested 3 weeks to
8 months later, to be assayed by FACS for the presence of each multipotent
progenitor population. The data were compared by pairwise Z-tests to
determine if differences were statistically significant. Within or beyond 6
weeks after reconstitution, mice reconstituted by Mac-1- CD4- c-kit+ cells
were significantly more likely (P<0.05 and P<0.01 respectively) than mice
reconstituted by either of the other progenitor populations to have detectable
donor-derived Mac-1 - CD4- c-kit+ or Mac-1loCD4 - cells. Mice reconstituted
by Mac-1loCD4- cells or Mac-1loCD4lo cells did not differ in the frequency of
recipients that contained donor progenitor populations.Multipotent progenitor populations form a lineage
Having demonstrated that the multipotent progenitor popula-
tions from normal bone marrow also exist in reconstituted
mice, we studied whether these populations form a lineage. As
described above, we found functional Mac-1- CD4- c-kit+,
Mac-1loCD4- and Mac-1loCD4lo progenitors in mice reconsti-
tuted by 60 Mac-1- CD4- c-kit+ cells. This demonstrates that the
Mac-1 - CD4- c-kit+ population has considerable self-renewal
potential as well as the ability to give rise to cells of both other
populations. If these populations form a lineage as hypoth-
esized, then mice reconstituted by Mac-1loCD4- cells should
contain donor-type Mac-1loCD4lo cells and possibly Mac-
1loCD4- cells but not Mac-1- CD4- c-kit+ cells. Similarly, mice
reconstituted by Mac-1loCD4lo cells should not contain donor-
type Mac-1- CD4- c-kit+ or Mac-1loCD4- cells. We systemati-
cally examined mice reconstituted by each population to test
this hypothesis. Unfortunately, as demonstrated above, cells
with the fluorescence profiles of Mac-1loCD4lo cells could
sometimes be isolated from reconstituted mice, even when
there was no progenitor activity in that population. It appears
that, in reconstituted mice, certain non-progenitor populations
can sometimes be indistinguishable from Mac-1loCD4lo pro-
genitors; therefore, a simple phenotypic analysis was insuffi-
cient for detecting Mac-1loCD4lo progenitors and functional
assays were required.
We phenotypically analyzed primary recipients reconstituted
by each multipotent progenitor population from normal
marrow for the presence of donor-derived Mac-1- CD4- c-kit+
or Mac-1loCD4- cells. The results are presented in Table 2.
Mice reconstituted by Mac-1- CD4- c-kit+ cells almost always
contained populations of donor-derived Mac-1 - CD4- c-kit+ and
Mac-1loCD4- cells no matter when the primary recipients were
analyzed, from 6 weeks to 8 months after reconstitution.Between 3 and 6 weeks after reconstitution by Mac-1- CD4 - c-
kit+ cells, four of nine mice had donor-derived Mac-1- CD4 - c-
kit+ and Mac-1loCD4- cells and two mice had donor Mac-1-
CD4- c-kit+ cells but not Mac-1loCD4- cells. Since mice were
reconstituted by only 60 Mac-1- CD4- c-kit+ cells, Poisson
statistics would predict that only two thirds of mice would have
their long-bones reconstituted at early time points. The third of
Mac-1 - CD4- c-kit+ reconstituted mice that did not contain
detectable donor-type progenitors before 6 weeks after recon-
stitution may not have had their long bones seeded by donor
progenitors. The higher frequency of Mac-1 - CD4 - c-kit+
reconstituted mice containing donor-derived progenitors at
later time points may reflect seeding of the long bones by donor
progenitors derived from other bones that were initially recon-
stituted. The frequencies of the donor-derived progenitor pop-
ulations were equal to or lower than the same populations in
age-matched normal bone marrow controls. The phenotypic
analyses are consistent with the functional analyses described
earlier in demonstrating that Mac-1- CD4- c-kit+ cells are
capable of long-term self-renewal as well as giving rise to Mac-
1loCD4- cells over the short-term and long-term.
Mac-1loCD4- and Mac-1loCD4lo cells usually only give rise
to transient reconstitution. In around 90% of cases, donor-type
myeloid cells in mice reconstituted by limit-dilution doses of
these populations become undetectable between 6 and 8 weeks
after reconstitution (Morrison and Weissman, 1994). After
reconstituted mice lost myeloid lineage chimerism, it was
never possible to transfer donor-type multipotent progenitor
activity to secondary recipients (data not shown). This demon-
strates that the vast majority of Mac-1lo progenitors self-renew
for less than 6 weeks; therefore, donor-derived multipotent
progenitors should mainly be found in primary recipients
within 6 weeks of reconstitution by limiting doses of transient
progenitors, if at all. In consideration of this, we split our
analyses of primary recipients into those conducted within 6
weeks of reconstitution and those conducted after 6 weeks of
reconstitution. Beyond 6 weeks after reconstitution by Mac-
1loCD4- cells, donor-derived Mac-1- CD4- c-kit+ or Mac-
1loCD4- populations were undetectable in the only primary
recipient available to be analyzed. Within 6 weeks after Mac-
1loCD4- reconstitution, donor-derived Mac-1- CD4- c-kit+ and
Mac-1loCD4- cells were only detected in 1 of 9 mice. Thus
Mac-1loCD4- cells were unable to consistently give rise to
Mac-1- CD4- c-kit+ cells. The observation of one recipient with
Mac-1- CD4- c-kit+ cells was consistent with the observation
that 15% of primary recipients reconstituted by Mac-1loCD4 -
cells become long-term multilineage reconstituted (Morrison
and Weissman, 1994), perhaps due to contamination by Mac-
1- CD4- c-kit+ progenitors. We were unable to observe con-
vincing evidence of Mac-1loCD4- self-renewal in the bone
marrow.
The Mac-1loCD4lo population gave rise to detectable Mac-
1- CD4- c-kit+ or Mac-1loCD4- cells in only one of ten recipi-
ents. The one recipient that contained both donor Mac-1- CD4 -
c-kit+ and Mac-1loCD4- cells was LTMR by donor-type cells.
It has previously been shown that 7% of Mac-1loCD4lo cells
yield LTMR (Morrison and Weissman, 1994).
In an effort to determine whether Mac-1loCD4- cells give
rise to Mac-1loCD4lo cells, Mac-1loCD4lo cells were purified
by two consecutive sorts from the bone marrow of three mice,
processed independently, that had been reconstituted by Mac-
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cells were transferred to each of nine secondary recipients in
a competitive reconstitution assay. One recipient died and one
recipient was unreconstituted by donor-type cells. Four
secondary recipients were TMR and three were reconstituted
only by donor B cells. Roughly equal proportions of transient
multipotent progenitor activity and B lineage progenitor
activity are also observed from Mac-1loCD4lo cells purified
from normal bone marrow. These data demonstrate that Mac-
1loCD4- cells give rise to functional Mac-1loCD4lo cells within
4 weeks of reconstitution.
Do Mac-1loCD4lo cells self-renew in the bone marrow? 2-4
weeks after reconstitution, Mac-1loCD4lo cells were purified by
two consecutive sorts from the bone marrow of two primary
recipients of Mac-1loCD4lo cells. 50 Mac-1loCD4lo cells were
transferred to each of five secondary recipients in competitive
reconstitution assays. None of these recipients became recon-
stituted by donor-type cells. The data suggest that most Mac-
1loCD4lo cells are not capable of sufficient self-renewal to be
detected in the bone marrow 2-4 weeks after reconstitution.
Mac-1loCD4 -- cells but not Mac-1loCD4lo cells self-
renew in the spleen
The Mac-1loCD4- and Mac-1loCD4lo populations did not exhibit
detectable self-renewal in the bone marrow, but it has been
observed that the spleen is the primary site of stem cell prolif-
eration at early times after reconstitution (Osawa et al., 1996).
We examined the ability of the Mac-1loCD4- and Mac-1loCD4lo
populations to self-renew or give rise to other multipotent pro-
genitor populations in the spleen at very early times after recon-
stitution. Lethally irradiated recipient-type mice were injected
with 35 cells of either donor-type progenitor population. 7 or 21
days after reconstitution, the spleens were examined by FACS
for the presence of multipotent progenitor populations (Table 3).
At 7 days after reconstitution, mice reconstituted by Mac-
1loCD4- cells always had greatly expanded numbers (0.01-
0.03%) of donor Mac-1loCD4- cells in their spleens, but did not
have Mac-1- CD4- c-kit+ cells detectable above background
(<0.002%). To confirm that this represented self-renewal ofTable 3. The presence of multipotent progenitor
populations in the spleens of mice reconstituted by Mac-
1loCD4 -- , or Mac-1loCD4lo cells from normal marrow
Donor-derived progenitors
Primary recipients Time after in primary recipients
reconstituted by reconstitution Mac-1- CD4- c-kit+ Mac-1loCD4 -
Mac-1loCD4 - 7 days 0/4 4/4
21 days 0/5 0/5
Mac-1loCD4lo 7 days 1/11 2/20
21 days 0/4 0/4
In each case, the number of primary recipients positive for each progenitor
population is shown as a proportion of recipients examined. Primary
recipients are organized according to the progenitor population that they were
reconstituted by. In each case, primary recipients were reconstituted by 35
donor-type cells of the given population and their spleens were harvested 7 or
21 days later to be assayed by FACS for the presence of each multipotent
progenitor population. The only significant difference between comparable
statistics was that Mac-1loCD4- progenitors were significantly more likely to
give rise to Mac-1loCD4- cells 7 days after reconstitution than Mac-1loCD4lo
progenitors (P<0.05).Mac-1loCD4- progenitors, these cells were isolated from the
spleens of reconstituted mice and were found to have day 12
CFU-S activity indistinguishable from the same population
isolated from normal bone marrow (1 colony for every 15 cells
injected). By 21 days after reconstitution, it was no longer
possible to detect the donor progenitor populations in the spleen.
Of mice reconstituted by Mac-1loCD4lo cells after 7 days, one
of eleven mice contained both Mac-1loCD4- and Mac-1- CD4-
c-kit+ cells and another mouse contained Mac-1loCD4- cells. By
21 days after reconstitution, donor progenitors were again no
longer detectable. At the dose of donor cells used, each spleen
should have been reconstituted by an average of two progenitor
cells based on CFU-S frequencies. Thus the occurrence of prog-
enitor populations in the spleens of mice reconstituted by Mac-
1loCD4lo cells could be explained by low levels of contamina-
tion from each of the Mac-1- CD4- c-kit+ and Mac-1loCD4-
populations. Alternately, it remains possible that Mac-1loCD4lo
cells can give rise to the other populations under rare circum-
stances. Overall, the spleen reconstitution data demonstrate that
at least half of Mac-1loCD4- cells have self-renewal potential
that can be observed in the spleen a week after reconstitution.
Self-renewal by Mac-1loCD4- cells at later times in the bone
marrow and/or spleen could occur but only at much lower levels
than we were unable to detect.
Most Mac-1loCD4lo cells do not exhibit detectable self-
renewal in the spleen. Two mice reconstituted by 35 Mac-
1loCD4lo cells 7 days earlier were examined by FACS for the
presence of Mac-1loCD4lo cells in their spleens. It was not
possible to isolate significant numbers (<0.002%) of Mac-
1loCD4lo cells from the spleens of either of these mice. An
additional five mice reconstituted by 35 Mac-1loCD4lo cells did
contain isolatable Mac-1loCD4lo cells 7 days after reconstitu-
tion, but these cells had no detectable day 12 CFU-S activity.
The lack of CFU-S activity in these cells is inconsistent with
them being transiently reconstituting multipotent progenitors
that arose by self-renewal of Mac-1loCD4lo cells transplanted
from normal marrow. As described above (Table 1), we were
often able to isolate cells from reconstituted mice with flu-
orescence profiles consistent with Mac-1loCD4lo progenitors,
but that had no detectable progenitor activity. We presume
these cells derive from some non-progenitor population that
coincidentally can appear similar to Mac-1loCD4lo progenitors
in reconstituted mice.
A quantitative estimate of self-renewal potential
Primary recipients in our experiments were reconstituted by 60
cells, such that the long bones were reconstituted by an average
of a single progenitor. The number of Mac-1- CD4- c-kit+ cells
found at later times in the long bones of these reconstituted
mice provides a quantitative measure of self-renewal potential.
4 weeks after reconstitution by Mac-1- CD4- c-kit+ cells, the
long bones of recipients contained 0.0046±0.0005% Mac-1-
CD4- c-kit+ cells. This corresponds to an average of 1400 Mac-
1- CD4- c-kit+ cells per recipient’s long bones. 8 months after
reconstitution, recipients averaged 0.03% Mac-1- CD4 - c-kit+
cells in the long bones. This corresponded to an average total
of 11,000 Mac-1- CD4- c-kit+ cells per recipient’s long bones.
This 11,000-fold expansion of a single Mac-1- CD4- c-kit+ cell
is likely to be an underestimate because some Mac-1- CD4- c-
kit+ cells were likely to have differentiated during 8 months of
hematopoiesis.
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their long bones seeded by donor-type progenitor cells in mice
injected with 60 cells (Henry et al., 1980). We transferred
whole bone marrow from the four long bones of mice injected
with 60 Mac-1- CD4- c-kit+ cells to secondary recipients. All
of the bone marrow recovered from the femurs and tibias of
each primary recipient was divided into aliquots and trans-
ferred along with 2· 105 recipient-type whole bone marrow
cells into each of 3-5 secondary recipients. Table 4 shows the
results. 2 weeks after reconstitution, only 50% of secondary
recipients were reconstituted by donor-type cells, consistent
with the prediction that only 63% of primary recipients should
have donor-type progenitors in their long bones. Over time,
however, the frequency of secondary recipients reconstituted
by donor-type cells increased to over 90%. At 4 weeks after
reconstitution, only half of the secondary recipients became
LTMR with donor-type cells. By 9 weeks after reconstitution,
and continuing for at least 8 months, over 90% of secondary
recipients became LTMR. This further demonstrates the
remarkable self-renewal potential of Mac-1- CD4- c-kit+ cells.
More importantly, they suggest that bones not initially seeded
by injected HSC can become reconstituted later by sufficient
donor-type HSC to transfer LTMR to multiple secondary recip-
ients. Perhaps the low-level circulation of HSC in blood
(Goodman and Hodgson, 1962) constantly redistributes prog-
enitors throughout all hematopoietic environments. On
average, efflux of HSC from the long bones may nearly equal
influx. If not, then the calculations above would underestimate
the self-renewal of HSC.
DISCUSSION
We have demonstrated that reconstituted mice contain the
same multipotent hematopoietic progenitor populations, with
similar properties, as normal bone marrow. Although the
progenitor populations purified from reconstituted mice are
less efficient at engrafting the bone marrow of recipient mice,
they function as well or almost as well as normal bone
marrow multipotent progenitors in CFU-S and in vitro assays
of multipotent progenitor activity. Mac-1 - CD4 - c-kit+ cells
and Mac-1loCD4 - cells from cytokine-mobilized mice
(Morrison et al., 1997) and from old mice (Morrison et al.,
1996b) are also less efficient than normal bone marrow HSC
at engrafting the bone marrow of irradiated recipients. In
those cases, both populations were as effective as normal
bone marrow HSC in forming primitive colonies in methyl-
cellulose, day 12 CFU-S, or long-term cultures on hematopoi-Table 4. Transfer of whole bone marrow from primary recip
Mac-1 -- CD4 -- c-kit+ cells at var
Donor cel
Long-term
Time of transfer n multilineage
2 weeks 29 3
4 weeks 12 50
8-9 weeks 16 81
9-10 months 24 92
Whole bone marrow from the four long bones of each primary recipient was us
number of secondary recipients reconstituted at each time point.etic stroma. It was proposed that the inefficient bone marrow
engraftment of multipotent progenitors from cytokine-
mobilized and old mice was due to changes in homing
receptor function that impaired homing to bone marrow. We
hypothesize that multipotent progenitors from reconstituted
mice are also less efficient at homing to and engrafting the
bone marrow. An alternate possibility is that, in reconstituted
mice, most cells with the surface marker phenotypes of mul-
tipotent progenitors may have differentiated into progenitors
that do not detectably engraft in vivo but which have late
CFU-S activity and form primitive colonies in vitro. While
this possibility should be acknowledged, no such progenitor
population has yet been identified; furthermore, the cytokine-
mobilized Mac-1 - CD4 - c-kit+ and Mac-1loCD4 - populations
did not appear to contain significant numbers of early myelo-
erythroid committed progenitors because few cells prolifer-
ated in response to IL-3 or GM-CSF alone (Morrison et al.,
1997). In support of the hypothesis that HSC from old,
cytokine-mobilized and reconstituted mice may have
different homing properties than normal HSC, we found a
change in adhesion molecule expression in all these circum-
stances, which could at least partially account for reduced
bone marrow engraftment (D. E. W., I. L. W., S. J. M., unpub-
lished data). In order to prove that HSC from reconstituted
mice are impaired in their bone marrow homing ability, it will
be necessary to directly follow the localization of such cells
in vivo after i.v. or intra-arterial injection. Such assays are not
currently possible with the small numbers of cells that can be
obtained from rare populations such as HSC.
Spangrude et al. (1995) found that Thy-1loSca-1+Lin-
Rho123lo cells purified from reconstituted mice did not exhibit
as much activity in competitive reconstitution assays as the
same cells from normal mice. They concluded that there is an
expansion of stem cell phenotype but not function in reconsti-
tuted mice. We agree that HSC from reconstituted mice do not
function as well as normal bone marrow HSC in competitive
reconstitution assays; however, our data demonstrate that the
majority of multipotent progenitors from reconstituted mice
behave much like normal multipotent progenitors in other
assays. We conclude that Mac-1- CD4- c-kit+ and Mac-1loCD4 -
cells in reconstituted mice are long-term and transiently self-
renewing HSC, but their ability to engraft mice is reduced,
perhaps by changes in homing properties. Changes in homing
properties could reduce engraftment by acting at any of a
number of levels. For example, such changes may confer the
tendency for progenitor cells to home to tissues not permissive
for hematopoiesis, or progenitors may be impaired in the
ability to adhere to bone marrow endothelium, or to extravasateients competitively reconstituted by 60 Thy-1lo Sca-1+ Lin --
ious times after reconstitution
l reconstitution profiles of secondary recipients (%)
Transient No donor cell
multilineage Oligoclonal reconstitution
7 38 52
42 8 0
6 13 0
4 0 4
ed to competitively reconstitute three to five secondary recipients. n refers to the
1938 S. J. Morrison and othersinto the marrow, or to localize to a permissive microenviron-
ment once inside the marrow.
The multipotent progenitor populations described in this
study form a lineage in which Mac-1- CD4- c-kit+ cells give rise
to Mac-1loCD4 - cells, which in turn give rise to functional
Mac-1loCD4lo cells. Most Mac-1- CD4- c-kit+ cells had long-
term self-renewal potential. At least half of Mac-1loCD4 - cells
had detectable, but transient self-renewal potential. Mac-
1loCD4lo cells had no detectable self-renewal potential. These
three populations include all multipotent progenitor cells iso-
latable from bone marrow (Uchida and Weissman, 1992).
Therefore, this lineage includes all multipotent progenitors
from long-term self-renewing HSC, to the most mature multi-
potent progenitors prior to, or in the process of, lineage com-
mitment.
HSC are defined by the ability of single cells to self-renew
and to give rise to all classes of blood cells (Siminovitch et al.,
1963; Morrison et al., 1995). It was previously demonstrated
that limit dilution doses of Mac-1- CD4- c-kit+ and Mac-
1loCD4- cells give rise to monocytes, granulocytes, B cells and
T cells (Morrison and Weissman, 1994). Limit dilution doses
of Mac-1loCD4lo cells sometimes exhibited multipotent pro-
genitor activity and sometimes only B lineage progenitor
activity (as observed in the blood) (Morrison and Weissman,
1994). The reduced colony formation in methylcellulose
culture by Mac-1loCD4lo cells from normal bone marrow
relative to the other multipotent progenitors from normal bone
marrow (Table 1) is consistent with Mac-1loCD4lo cells con-
taining lymphoid committed progenitors. At the population
level, Thy-1loSca-1+Lin- /lo cells also give rise to erythrocytes,
platelets (Uchida et al., 1994) and natural killer cells (Aguila,
Uchida, Weissman unpublished data). Therefore cells in the
Mac-1- CD4- c-kit+ and Mac-1loCD4- populations may be
pluripotent. This study is the first in which the self-renewal
potentials of each Thy-1loSca-1+Lin- /lo subpopulation is
explicitly examined. Most Mac-1 - CD4- c-kit+ and Mac-
1loCD4- cells had self-renewal potential, while there was no
evidence for self-renewal of Mac-1loCD4lo cells. Thus both
Mac-1- CD4- c-kit+ and Mac-1loCD4- populations fulfill the
criteria of HSC (Siminovitch et al., 1963), but Mac-1loCD4lo
cells do not. Those who would define HSC as having long-term
self-renewal potential might consider only the Mac-1 - CD4- c-
kit+ subset as HSC, but this is a semantic issue.
The markers used to identify the progenitor populations
described in this study allow the purification of multipotent
progenitors and the separation of long-term and transient pro-
genitors. Nonetheless, the Mac-1- CD4- c-kit+, Mac-1loCD4- ,
and Mac-1loCD4lo populations do not perfectly separate long-
term and transient progenitors (Morrison and Weissman,
1994). In the same way, the data in Tables 2 and 3 demonstrate
that in a low frequency of reconstituted mice, progenitor pop-
ulations can be detected that would not be predicted by the
lineage hypothesis. The frequency of such observations is con-
sistent with the frequency of long-term self-renewing progen-
itors observed within the transiently reconstituting populations
(Morrison and Weissman, 1994). Given the limitations in the
ability to completely eliminate long-term progenitors from
Mac-1lo populations, the data are consistent with the lineage
hypothesis. However, it is also possible that, under rare cir-
cumstances, a Mac-1lo progenitor might give rise to a long-
term reconstituting Mac-1- progenitor. If this were true, thethree populations would still form a lineage as demonstrated,
but under rare circumstances the lineage might operate in
reverse. The data in this and previous studies rule out the pos-
sibility that the three multipotent progenitor populations only
arise from additional progenitor population(s).
Lineages of committed hematopoietic progenitors have pre-
viously been identified in the B (Hardy et al., 1991) and T (for
example Guidos et al., 1990; Shortman, 1992; Kraft et al.,
1993; Wu et al., 1996) lineages. The identification of a lineage
of multipotent progenitors, in which each intermediate can be
independently purified, provides a tool for elucidating the
genetic regulation of self-renewal and lineage commitment.
Each population in this lineage is similar in phenotype and
developmental potential. Yet within the lineage there is a tran-
sition from long-term to undetectable self-renewal potential.
Similarly, Mac-1 - CD4- c-kit+ cells are pluripotent, while Mac-
1loCD4lo cells may be in the process of lineage commitment.
The genes whose expression regulates self-renewal or the
earliest stages of lineage commitment should be differentially
expressed by the populations of this lineage. Using single cell
analyses of gene expression and enzyme activity, we have iden-
tified candidate genes involved in the regulation of self-renewal
and lineage commitment. Telomerase (Morrison et al., 1996a)
and Ikaros isoforms (C. Klug, S. J. M., I. L. W., unpublished
data) are differentially expressed among the multipotent prog-
enitor populations. We expect that further analyses will yield
more extensive insight into which genes regulate self-renewal
and lineage commitment.
We thank Libuse Jerabek for laboratory management, Tim Knaak
and Jack Sun for FACS machine operation, Veronica Braunstein and
Andraea Nicolau for antibody preparation, Lucino Hidalgo and
Ricardo Salazaar for animal care. Thanks to Koichi Akashi for expert
assistance with methylcellulose assays. S. J. M. was a Howard Hughes
Medical Institute Predoctoral Fellow. D. E. W. is a Howard Hughes
Medical Institute Medical Student Fellow. This work was supported
by National Cancer Institute Grant CA42551.
REFERENCES
Goodman, J. W. and Hodgson, G. S. (1962). Evidence for stem cells in the
peripheral blood of mice. Blood 19, 702-714.
Guidos, C. J., Danska, J. S., Fathman, C. G. and Weissman, I. L. (1990). T
cell receptor-mediated negative selection of autoreactive T lymphocyte
precursors occurs after commitment to the CD4 or CD8 lineages. J. Exp.
Med. 172, 835-846.
Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. and Hayakawa,
K. (1991). Resolution and characterization of pro-B and pre-pro-B cell stages
in normal mouse bone marrow. J. Exp. Med. 173, 1213-1225.
Heimfeld, S., Hudak, S., Weissman, I. and Rennick, D. (1991). The in vitro
response of phenotypically defined mouse stem cells and myeloerythroid
progenitors to single or multiple growth factors. Proc. Natl. Acad. Sci., USA
88, 9902-9906.
Hellman, S., Botnick, L. E., Hannon, E. C. and Vigneulle, R. M. (1978).
Proliferative capacity of murine hematopoietic stem cells. Proc. Natl. Acad.
Sci., USA 75, 490-494.
Henry, C., Marbrook, J., Vann, D. C., Kodlin, D. and Wofsy, C. (1980).
Limiting dilution analysis. In Selected Methods in Cellular Immunology’ (ed.
B. B. Mishell and S. M. Shiigi), pp. 138-152. San Francisco, California: W.J.
Freeman and Company. 
Kay, H. E. M. (1965). How many cell-generations? Lancet 2, 418-419.
Kraft, D. L., Weissman, I. L. and Waller, E. K. (1993). Differentiation of
CD3-4-8- human fetal thymocytes in vivo: characterization of a CD3-4+8-
intermediate. J. Exp. Med. 178, 265-277.
Micklem, H. S. and Ogden, D. A. (1976). Aging of hematopoietic stem cell
1939Stem cell lineagepopulations in the mouse. In Stem Cells of Renewing Cell Populations (ed. A.
B. Cairnie, P. K. Lala, and D. G. Osmond), pp. 331-341. New York:
Academic Press.
Morrison, S., Prowse, K. R., Ho, P. and Weissman, I. (1996a). Telomerase
activity in hematopoietic cells is associated with self-renewal potential.
Immunity 5, 207-216.
Morrison, S. J., Uchida, N. and Weissman, I. L. (1995). The biology of
hematopoietic stem cells. Annual Reviews in Cell and Developmental
Biology 11, 35-71.
Morrison, S. J., Wandycz, A. M., Akashi, K., Globerson, A. and Weissman,
I. L. (1996b). The aging of hematopoietic stem cells. Nature Medicine 2,
1011-1016.
Morrison, S. J. and Weissman, I. L. (1994). The long-term repopulating
subset of hematopoietic stem cells is deterministic and isolatable by
phenotype. Immunity 1, 661-73.
Morrison, S. J., Wright, D. E. and Weissman, I. L. (1997).
Cyclophosphamide/G-CSF induces hematopoietic stem cells to proliferate
prior to mobilization. Proc. Natl. Acad. Sci., USA 94, 1908-1913.
Muller-Sieburg, C. E. and Riblet, R. (1996). Genetic control of the frequency
of hematopoietic stem cells in mice: mapping of a candidate locus to
chromosome 1. J. Exp. Med. 183, 1141-1150.
Osawa, M., Nakamura, K., Nishi, N., Takahashi, N., Tokuomoto, Y., Inoue,
H. and Nakauchi, H. (1996). In vivo self-renewal of c-kit+ Sca-1+ Linlow/-
hemopoietic stem cells. J. Immunol. 156, 3207-3214.
Parks, D. R. and Herzenberg, L. A. (1984). Fluorescence activated cell
sorting: theory, experimental optimization, and applications in lymphoid cell
biology. Methods in Enzymology 108, 197-241.
Rosendaal, M., Hodgson, G. S. and Bradley, T. R. (1979). Organization of
haemopoietic stem cells: the generation age hypothesis. Cell and Tissue
Kinetics 12, 17-29.Shortman, K. (1992). Cellular aspects of early T-cell development. Current
Opinion in Immunology 4, 140-146.
Siminovitch, L., McCulloch, E. and Till, J. (1963). The distribution of
colony-forming cells among spleen colonies. J. Cell. Comp. Physiol. 62, 327-
336.
Smith, L. H. and Clayton, M. L. (1970). Distribution of injected 59Fe in mice.
Experimental Hematology 20, 82-86.
Spangrude, G. J., Brooks, D. M. and Tumas, D. B. (1995). Long-term
repopulation of irradiated mice with limiting numbers of purified
hematopoietic stem cells: in vivo expansion of stem cell phenotype but not
function. Blood 85, 1006-16.
Spangrude, G. J., Heimfeld, S. and Weissman, I. L. (1988). Purification and
characterization of mouse hematopoietic stem cells. Science 241, 58-62.
Tsuji, K., Lyman, S. D., Sudo, T., Clark, S. C. and Ogawa, M. (1992).
Enhancement of murine hematopoiesis by synergistic interactions between
steel factor (ligand for c-kit), interleukin-11, and other early acting factors in
culture. Blood 79, 2855-2860.
Uchida, N., Aguila, H. L., Fleming, W. H., Jerabek, L. and Weissman, I. L.
(1994). Rapid and sustained hematopoietic recovery in lethally irradiated
mice transplanted with purified Thy-1.1lo Lin- Sca-1+ hematopoietic stem
cells. Blood 83, 3758-79.
Uchida, N. and Weissman, I. L. (1992). Searching for hematopoietic stem
cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in
C57BL/Ka-Thy-1.1 bone marrow. J Exp Med 175, 175-84.
Wu, L., Li, C.-L. and Shortman, K. (1996). Thymic dendritic cell precursors:
relationship to the T lymphocyte lineage and phenotype of the dendritic cell
progeny. J. Exp. Med. 184, 903-911.
(Accepted 6 March 1997)
